Coverage / TLX / Trade Card

TLX

Telix Pharmaceuticals American Depositary Shares

OPPORTUNISTIC BUY 2026-08-06 Updated today USD 10.64 AWAIT ENTRY
59

Position levels

Currenttoday
USD 10.64
Buy <=wait / entry
USD 9.33
Trim >=take some off
USD 14.00
Thesis breakA negative TLX591-Tx clinical readout, a material Illuccix growth disappointment...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case26%100 / 10026.0
Base case49%62 / 10030.4
Bear case25%10 / 1002.5
Weighted conviction59 / 100 - OPPORTUNISTIC BUY

Top risks

  • Strong Buy consensus from 4 analysts with average price target of $21.13
  • FDA alignment on clinical trial protocols, statistical analysis plans and safety monitoring for TLX591-Tx
  • Current revenue from US sales of Illuccix
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.